Novavax is trading at $9.62 (-12.58%) amid a global risk-off move, which may not explain the full decline. - Available coverage identified no clear company-specific catalyst for the October 22 decline. - Market reporting cited rising oil prices and renewed geopolitical concerns pressuring growth stocks. - Technology shares also weakened as investors reassessed AI spending and risk sentiment deteriorated.